Cynosure Group’s Halozyme HALO Stock Holding History

Cynosure Group’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,063	Closed	-$475K	–	318
2025 Q4	$475K	Buy	+7,063	New	+$475K	0.05%	222

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cynosure Group's HALO Position: Q1 2026 in Review

Cynosure Group sold out of Halozyme (HALO) in Q1 2026, closing a stake of 7,063 shares — an estimated $475K sold.

Cynosure Group first reported a position in HALO in Q4 2025 and held it in 1 quarter. The position peaked at $475K in Q4 2025. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

Cynosure Group reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
Cynosure Group sold 7,063 Halozyme shares in Q1 2026, an estimated $475K.
Cynosure Group first reported a position in Halozyme in Q4 2025 and held it in 1 quarter.
Cynosure Group's Halozyme position peaked at $475K in Q4 2025.
635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Cynosure Group's 13F filing for Q1 2026, filed 14 May 2026.